期刊文献+

氯沙坦改善3T3-L1脂肪细胞胰岛素抵抗的机制研究 被引量:3

Mechanism of losartan in treatment of insulin resistance in 3T3-L1 adipocytes
下载PDF
导出
摘要 目的探讨氯沙坦改善3T3-L1脂肪细胞胰岛素抵抗的主要作用机制。方法以地塞米松诱导3T3-L1脂肪细胞,建立胰岛素抵抗细胞模型,根据细胞模型添加干预药物的不同分为模型对照组(不添加任何药物)、氯沙坦组(分别给予1、10、100μmol/L氯沙坦干预48 h)和wortmannin+氯沙坦组,wortmannin+氯沙坦组以100 nmol/L的磷脂酰肌醇3激酶(PI3K)特异性抑制剂wortmannin预处理20 min后再加入100μmol/L氯沙坦干预48 h。观察脂肪细胞体积的变化,采用葡萄糖氧化酶法检测细胞培养上清液中葡萄糖的浓度,采用Western blotting分析脂肪细胞中PI3K和胰岛素受体底物1(IRS-1)的表达以及IRS-1丝氨酸磷酸化水平。结果与模型对照组比较,氯沙坦组脂肪细胞体积明显缩小(P<0.01),细胞培养上清液中葡萄糖的浓度显著降低(P<0.01),PI3K和IRS-1表达明显上升(P<0.01),IRS-1丝氨酸磷酸化水平显著下降(P<0.01)但可被wortmannin阻断。结论氯沙坦可使3T3-L1脂肪细胞胰岛素抵抗模型的细胞体积缩小,并增加细胞对葡萄糖的利用,其机制可能与PI3K信号通路有关。 Objective To investigate the main mechanism of losartan in treatment of insulin resistance in 3T3-L1 adipocytes. MethodsThe model of insulin resistance in 3T3-L1 adipocytes was induced by dexamethasone.Model control group(without treatment with any drug),losartan group(treatment with 1 μmol/L,10 μmol/L and 100 μmol/L losartan for 48 h respectively) and wortmannin+losartan group were divided.Adipocytes in wortmannin+losartan group were pretreated with 100 nmol/L wortmannin,phosphatidylinositol 3-kinase(PI3K) inhibitor for 20 min,and were treated with 100 μmol/L losartan for 48 h.The size of adipocytes was observed,glucose oxidase method was employed to measure the glucose concentration in supernatant of culture fluid,and Western blotting was adopted to detect the expression of PI3K and insulin receptor substrate 1(IRS-1) and level of IRS-1 serine phosphorylation in adipocytes. ResultsCompared with model control group,the size of adipocytes significantly reduced(P0.01),the glucose concentration in supernatant of culture fluid significantly decreased(P0.01),the expression of PI3K and IRS-1 significantly increased(P0.01).The level of IRS-1 serine phosphorylation significantly decreased compared with model control group(P0.01),but the effect could be blocked by wortmannin. ConclusionLosartan could significantly decrease the cell size and increase the consumption of glucose in 3T3-L1 adipocytes with insulin resistance,and the mechanism might be associated with PI3K pathway.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2011年第12期1702-1706,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市宝山区科委基金(08-E-8)~~
关键词 氯沙坦 脂肪细胞 胰岛素抵抗 losartan adipocyte insulin resistance
  • 相关文献

参考文献18

  • 1Booth GL,Kapral MK,Fung K,et al.Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people:a population-based retrospective cohort study[J].Lancet,2006,368(9529):29-36.
  • 2Koenen TB,Tack CJ,Kroese JM,etal.Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients[J].J Clin Endocrinol Metab,2009,94(11):4453-4457.
  • 3Aksnes TA,Flaa A,Sevre K,etal.Effects on plasma noradrenaline may explain some of the improved insulin sensitivity seen by AT-1 receptor blockade[J].Blood Press,2008,17(3):156-163.
  • 4Watanabe S,Okura T,Kurata M,et al.The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension[J].Clin Ther,2006,28(10):1677-1685.
  • 5Lee MH,Song HK,Ko GJ,etal.Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue[J].J Kidney Int,2008,74(7):890-900.
  • 6Chang E,Donkin SS,Teegarden D.Parathyroid hormone suppresses insulin signaling in adipocytes[J].Mol Cell Endocrinol,2009,307(1-2):77-82.
  • 7王丽静,张尉,刘小莺,黄培基,刘礼斌.地塞米松诱导3T3-L1脂肪细胞胰岛素抵抗模型的建立[J].福建医科大学学报,2007,41(3):282-284. 被引量:29
  • 8Tamori Y,Masugi J,Nishino N,et al.Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes[J].Diabetes,2002,51 (7):2045-2055.
  • 9Heydrick SJ,Gautier N,Olichon-Berthe C,et al.Early alteration of insulin stimulation of PI 3-kinase in muscle and adipocyte from gold thioglucose obese mice[J].Am J Physiol,1995,268(4 Pt 1):E604-E612.
  • 10Munoz MC,Giani JF,Dominici FP,et al.Long-term treatment with an angiotensin Ⅱ receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats[J].J Hypertens,2009,27 (12):2409-2420.

二级参考文献16

  • 1刘礼斌,刘小莺,王艳萍,林哲章,张闿珍.肥胖和2型糖尿病血浆脂联素水平及与体质量指数的相关性[J].福建医科大学学报,2004,38(4):414-415. 被引量:2
  • 2卢慧玲,王宏伟,林汉华.促酰化蛋白诱导3T3-F442A前脂肪细胞分化的研究[J].中国病理生理杂志,2005,21(2):243-246. 被引量:4
  • 3Cederberg A,Enerback S.Insulin resistance and type 2 diabetes-an adipocentric view[J].Curr Mol Med,2003,3 (2):107-125.
  • 4Faraj M,Lu HL,Cianflone K.Diabetes,lipids,and adipocyte secretagogues[J].Biochem Cell Biol,2004,82(1):170-190.
  • 5van Epps-Fung M,Williford J,Wells A,et al.Fatty acid-induced insulin resistance in adipocytes[J].Endocrinology,1997,138 (10):4338 -4345.
  • 6Sinha S,Perdomo G,Brown NF,et al.Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B[J].J Biol Chem,2004,279 (40):41294 -41301.
  • 7Lundgren M,Eriksson JW.No in vitro effects of fatty acids on glucose uptake,lipolysis or insulin signaling in rat adipocytes[J].Horm Metab Res,2004,36(4):203-209.
  • 8Chavez JA,Summers SA.Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes[J].Arch Biochem Biophys,2003,419(2):101-109.
  • 9Hideyuki S,Takehide O,Motonobu A,et al.Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction[J].Diabetes,2000,49(10):1700-1708.
  • 10Brent C,Daniel M.Insulin receptor synthesis and turnover in differentiating 3T3-L1 preadipocytes[J].Proc Natl Acad Sci USA,1980,77(1):285-289.

共引文献48

同被引文献29

  • 1郭晓农,杨具田,牛峰,张汝学,贾正平.胰岛素抵抗3T3-L1脂肪细胞模型的建立及鉴定[J].中药材,2008,31(2):258-261. 被引量:13
  • 2王丽静,张尉,刘小莺,黄培基,刘礼斌.地塞米松诱导3T3-L1脂肪细胞胰岛素抵抗模型的建立[J].福建医科大学学报,2007,41(3):282-284. 被引量:29
  • 3杨智勇,赵晟,夏婷婷,李晓东.脂联素、核因子-κB在胰岛素抵抗大鼠表达[J].解剖科学进展,2007,13(2):131-133. 被引量:4
  • 4You LIU,Qun WANG,Ying-bin PAN,Zhi-jie GAO,Yan-fen LIU,Shao-hong CHEN.Effects of over-expressing resistin on glucose and lipid metabolism in mice[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2008,9(1):44-50. 被引量:12
  • 5Utzschneider KM,Kahn SE.Review:The role of insulin resistance in nonalcoholic fatty liver disease[J].J Clin Endocrinol Metab,2006,91(12):4753-4761.
  • 6Bartomiej Orlik,Gabriela Handzlik,Magdalena Olszanecka-Glinianowicz.The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease[J].Postepy Hig Med Dosw(online),2010,64(1):212-219.
  • 7Diehl AM.Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease[J].Clinics in liver disease,2004,8(3):619-638.
  • 8Polyzos SA,Kountouras J,Zavos C.Nonalcoholic Fatty Liver Disease:The pathogenetic roles of insulin resistance and adipocytokines[J].Current Molecular Medicine,2009,9(3),299-314.
  • 9Habecker BA,Martin JM,Nathanson NM.Isolation and characterization of a novel c DNA which identifies both neural-specific and ubiquitously expressed GS alpha mRNAs[J].J Neurochem,1993,61(2):712-718.
  • 10Monzillo LU,Hamdy O,Horton ES,et al.Effect of lifestyle modificationm on adipokine levels in obese subjects with insulin resistance[J].Obes Res,2003,11(9):1048-1054.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部